SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
Johnson & Johnson at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Johnson & Johnson brings 4 presentations to SITC 2026 in Phoenix. Its program centres on T-cell engagers and other bispecific antibodies, how they compare with cell therapy, and on launching biotech startups. A distinctive finding is that blocking IL-12/23 reduces the immune-related side effects of checkpoint drugs in preclinical models without losing their anti-tumor effect.
| Organization | SITC 2026 Attendance |
|---|---|
Johnson & Johnson New Brunswick, NJ | |
Pharmaceutical business of Johnson & Johnson, formerly Janssen, developing oncology medicines including bispecific antibodies and cell therapy. | Talk Thu Nov 5 11:30am–11:50am Talk Thu Nov 5 10:05am–10:20am Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships
Talk Fri Nov 6 3:05pm–3:20pm |
Find decision makers at Johnson & Johnson
Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction